Invasive Pulmonary Aspergillosis in Lung Transplant Recipients: Retrospective Clinical Analysis from a Tertiary

Sibel Doğan Kaya1, Yeşim Uygun Kızmaz1, Aysu Türkmen Karaağaç2

  • 1Infectious Diseases and Clinical Microbiology Department, Koşuyolu High Specialization Training and Research Hospital, 34865 Istanbul, Türkiye.

PubMed
Abstract

Insights

Pulmonary aspergillosis affects 9% of lung transplant recipients (LTRs), leading to a 15% mortality rate. Early diagnosis and intervention are crucial for improving survival in these high-risk patients.

Area of Science:

  • Medical Mycology
  • Transplant Infectious Diseases
  • Pulmonology

Background:

  • Aspergillosis is a significant invasive fungal infection in lung transplant recipients (LTRs).
  • It presents diagnostic challenges and high mortality rates, comparable to bacterial or viral infections.
  • Tertiary care centers focus on evaluating pulmonary aspergillosis in LTRs.

Purpose of the Study:

  • To evaluate pulmonary aspergillosis cases in a tertiary lung transplant center.
  • To identify the incidence and characteristics of Aspergillus infections in LTRs.
  • To assess diagnostic methods and outcomes for aspergillosis in this population.

Main Methods:

  • Retrospective analysis of 146 LTRs.
  • Recorded demographic data, microbiological, histopathological, and radiological findings.
  • Focused on Aspergillus identification methods.

Main Results:

  • Aspergillus spp. detected in 9% (13/146) of LTRs.
  • Common pathogens included Aspergillus Terreus (21%), A. Fumigatus (14%), and A. Flavus (14%).
  • Mortality rate was 15%; PCR in bronchoalveolar lavage was positive in 61.5% of cases.

Conclusions:

  • Lung transplant recipients face a high risk of Aspergillus infections.
  • Early diagnosis through combined microbiological, histopathological, and radiological methods is vital.
  • Integrated prevention, prophylaxis, and treatment strategies enhance patient survival.